alexa Abstract | Method Development and Validation for Simultaneous Estimation of Emtricitabine and Tenofovir Disoproxil Fumarate in Pure and Tablet Dosage Form by using RP-HPLC


Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Research Article Open Access

Abstract

A simple, precise, accurate and rapid RP-HPLC method with PDA detector has been developed and subsequently validated for the simultaneous estimation of emtricitabine and tenofovir disoproxil fumarate in pure and tablet dosage form. The estimation was carried out on a Phenomenax Luna C18 (250mm x 4.6mm i.d; particle size 5μm) column with mixture of methanol: phosphate buffer pH-3 (70:30 v/v) as mobile phase. The flow rate was 1ml/min. UV detection was performed at 258 nm. The method was validated for linearity, accuracy, precision, robustness, LOD, LOQ as per ICH guidelines. The developed and validated method was successfully used for the quantitative analysis of commercial available dosage form. The retention time was 2.605 min and 3.781 min for emtricitabine and tenofovir disoproxil fumarate, respectively. The calibration curve was linear over concentration range of 45-105μg/ml for tenofovir disoproxil fumarate and 30-70μg/ml for emtricitabine. The correlation coefficient (r2) was found to be 0.999.Amount of emtricitabine and tenofovir disoproxil fumarate was found to be 199.4mg/tab and 298.6mg/tab respectively. The %RSD values were less than 2 for method precision. LOD and LOQ were found to be limits for emtricitabine and tenofovir disoproxil fumarate. The high percentage of recovery and low percentage coefficient of variance confirm the suitability of the method for the simultaneous estimation of emtricitabine and tenofovir disoproxil fumarate in pure and tablet dosage form.

To read the full article Peer-reviewed Article PDF image

Author(s): Deepthi Komaroju, G. Nagarjuna Reddy, K. Dhanalakshmi

Recommended Journals

Share This Page

Additional Info

Loading
Loading Please wait..
 
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords